MDM2 SNP309 and TP53 SNPArg72Pro Polymorphisms in Myelodysplastic Syndrome.

被引：0
|
作者：
Machado Neto, Joao Agostinho [1 ]
Traina, Fabiola [1 ]
Campos, Paula Melo [1 ]
Andreoli, Marilisia [1 ]
Metze, Irene Lorand [1 ]
Costa, Fernando Ferreira [1 ]
Saad, Sara T. O. [1 ]
机构：
[1] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, SP, Brazil
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
MDM2; p53; myelodysplasia; polymorphisms;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：693 / 694
页数：2
相关论文
共 50 条
  • [31] Combined effects of single nucleotide polymorphisms TP53 R72P and MDM2 SNP309, and p53 expression on survival of breast cancer patients
    Schmidt, Marjanka K.
    Tommiska, Johanna
    Broeks, Annegien
    van Leeuwen, Flora E.
    Van't Veer, Laura J.
    Pharoah, Paul D. P.
    Easton, Douglas F.
    Shah, Mitul
    Humphreys, Manjeet
    Dork, Thilo
    Reincke, Scarlett A.
    Fagerholm, Rainer
    Blomqvist, Carl
    Nevanlinna, Heli
    BREAST CANCER RESEARCH, 2009, 11 (06):
  • [32] MDM2 SNP309 and p53 Codon 72 Genetic Polymorphisms and Risk of AML: an Egyptian Study
    El-Danasouri, Nabil Mohsen
    Ragab, Shadia Hassan
    Rasheed, Maha Ameen
    El Saadany, Zainab Ali
    Abd El-Fattah, Safa Nabil
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2014, 44 (04): : 449 - 454
  • [33] MDM2 SNP309 and p53 Codon 72 Genetic Polymorphisms and Risk of AML: An Egyptian Study
    ZainabElsaadany
    El-Danasouri, Nabil
    Nabil, Safa
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S27 - S27
  • [34] Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore
    Woon-Puay Koh
    David Van Den Berg
    Aizhen Jin
    Renwei Wang
    Jian-Min Yuan
    Mimi C. Yu
    Breast Cancer Research and Treatment, 2011, 130 : 1011 - 1019
  • [35] Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder
    Horikawa, Yohei
    Nadaoka, Junichi
    Saito, Mitsuru
    Kumazawa, Teruaki
    Inoue, Takamitu
    Yuasa, Takeshi
    Tsuchiya, Norihiko
    Nishiyama, Hiroyuki
    Ogawa, Osamu
    Habuchi, Tomonori
    ONCOLOGY REPORTS, 2008, 20 (01) : 49 - 55
  • [36] MDM2 SNP309 and p53 Arg72Pro in cutaneous melanoma: association between SNP309 GG genotype and tumor Breslow thickness
    Capasso, Mario
    Ayala, Fabrizio
    Avvisati, Rosa Anna
    Russo, Roberta
    Gambale, Antonella
    Mozzillo, Nicola
    Ascierto, Paolo Antonio
    Iolascon, Achille
    JOURNAL OF HUMAN GENETICS, 2010, 55 (08) : 518 - 524
  • [37] Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore
    Koh, Woon-Puay
    Van den Berg, David
    Jin, Aizhen
    Wang, Renwei
    Yuan, Jian-Min
    Yu, Mimi C.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 130 (03) : 1011 - 1019
  • [38] Association of the germline MDM2 SNP309 and TP53 R72P variants with breast cancer survival in specific tumour subgroups
    van den Broek, A. J.
    Broeks, A.
    Horlings, H.
    Braaf, L. M.
    Van't Veer, L. J.
    Schmidt, M. K.
    EJC SUPPLEMENTS, 2010, 8 (03): : 89 - 89
  • [39] MDM2 SNP309 and p53 Arg72Pro in cutaneous melanoma: association between SNP309 GG genotype and tumor Breslow thickness
    Mario Capasso
    Fabrizio Ayala
    Rosa Anna Avvisati
    Roberta Russo
    Antonella Gambale
    Nicola Mozzillo
    Paolo Antonio Ascierto
    Achille Iolascon
    Journal of Human Genetics, 2010, 55 : 518 - 524
  • [40] CLINICAL IMPLICATIONS OF THE MDM2 SNP309 AND P53 ARG72PRO POLYMORPHISMS IN TRANSITIONAL CELL CARCINOMA OF THE BLADDER.
    Horikawa, Yohei
    Nadaoka, Jyunichi
    Saito, Mitsuru
    Kumazawa, Teruaki
    Yuasa, Takeshi
    Tsuchiya, Norihiko
    Ogawa, Osamu
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2009, 181 (04): : 346 - 346
12345